Literature DB >> 33975060

A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis.

Ying Zhu1, Jianbo Tian1, Xiating Peng1, Xiaoyang Wang1, Nan Yang1, Pingting Ying1, Haoxue Wang1, Bin Li1, Yue Li1, Ming Zhang1, Yimin Cai1, Zequn Lu1, Siyuan Niu1, Yao Li1, Rong Zhong1, Jiang Chang2, Xiaoping Miao3.   

Abstract

AIM: This study aimed to identify the functional genes and genetic variants associated with the prognosis of pancreatic ductal adenocarcinoma (PDAC) and reveal the mechanism underlying their prognostic roles.
METHODS: First, we implement a two-stage exome-wide association study in a total of 1070 patients to identify the genetic variant correlated with PDAC prognosis. Then we performed fine mapping through bioinformatics analysis and dual-luciferase reporter assays to reveal the causal functional variant and prognostic gene. Next, we established the gene knockdown, knockout, and overexpression cell lines with small interfering RNA, CRISPR/Cas9, and lentivirus, respectively, and investigated the gene function on cell proliferation and migration in vivo and in vitro. Finally, we performed the RNA-seq to elucidate downstream genes and mechanisms altering PDAC prognosis.
RESULTS: We identified the CAV1-CAV2 locus tagged by rs8940 was significantly associated with PDAC prognosis, and rs10249656 in the 3'untranslated region of CAV2 was the real functional variant, which upregulated CAV2 expression through abolishing miR-548s binding. We observed upregulated CAV2 in PDAC and the higher expression correlated with worse prognosis. Transient knockdown of CAV2 inhibited PDAC migration without affecting proliferation rate. Knockout of CAV2 suppressed PDAC progression and metastasis, whereas stable overexpression of CAV2 promoted. Overexpressed CAV2 promoted the PDAC progression and metastasis via perturbing genes in the focal adhesion (CCND1, IGTA1, and ZYX) and extracellular matrix organisation (PLOD2, CAST, and ITGA1) pathways mechanically.
CONCLUSION: These findings shed light on an important role of CAV2 on PDAC progression and the prognostic impact of its genetic variation.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CAV2; Genetic variation; Metastasis; Pancreatic cancer; Survival

Year:  2021        PMID: 33975060     DOI: 10.1016/j.ejca.2021.04.008

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  3 in total

1.  CAV2 Regulates Mir-4723/Wnt7A Signalling Axis through Endocytosis and Epithelial-Mesenchymal Transition to Promote Proliferation, Invasion, and Metastasis of Pancreatic Cancer Cells.

Authors:  Dan Li; Yuting Guo; She Tian; Changhao Zhu; Chengyi Sun
Journal:  J Cancer       Date:  2022-04-04       Impact factor: 4.478

2.  CAV2 promotes the invasion and metastasis of head and neck squamous cell carcinomas by regulating S100 proteins.

Authors:  Yafei Wang; Yun Wang; Ruoyan Liu; Chunli Wang; Yi Luo; Liwei Chen; Yuchao He; Keyun Zhu; Hua Guo; Ze Zhang; Jingtao Luo
Journal:  Cell Death Discov       Date:  2022-09-16

Review 3.  Interpretation of the role of germline and somatic non-coding mutations in cancer: expression and chromatin conformation informed analysis.

Authors:  Michael Pudjihartono; Jo K Perry; Cris Print; Justin M O'Sullivan; William Schierding
Journal:  Clin Epigenetics       Date:  2022-09-28       Impact factor: 7.259

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.